Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-08-23
2011-08-23
Wilson, James O (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S114000
Reexamination Certificate
active
08003662
ABSTRACT:
Compounds of Formula I and pharmaceutically acceptable salts thereof, are useful for inhibiting receptor tyrosine kinases and for treating disorders mediated thereby. Methods of using compounds of Formula I and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
REFERENCES:
patent: 6492383 (2002-12-01), Munchhof et al.
patent: 6833456 (2004-12-01), Romines, III et al.
patent: 6869962 (2005-03-01), Collins et al.
patent: 6964961 (2005-11-01), Luzzio et al.
patent: 6987116 (2006-01-01), Boschelli et al.
patent: 6995171 (2006-02-01), Autry et al.
patent: 2002/0004511 (2002-01-01), Luzzio et al.
patent: 2004/0138251 (2004-07-01), Boschelli et al.
patent: 2004/0242603 (2004-12-01), Fujiwara et al.
patent: 2005/0009845 (2005-01-01), Caferro et al.
patent: 2005/0070508 (2005-03-01), Lou et al.
patent: 2005/0090509 (2005-04-01), Lou et al.
patent: 2005/0239820 (2005-10-01), Borzilleri et al.
patent: 2005/0245530 (2005-11-01), Borzilleri et al.
patent: 2006/0074056 (2006-04-01), Vaisburg et al.
patent: 2006/0252777 (2006-11-01), Kim et al.
patent: 2006/0287343 (2006-12-01), Saavedra et al.
patent: 2007/0004675 (2007-01-01), Saavedra et al.
patent: 2007/0054928 (2007-03-01), Bannen et al.
patent: 2007/0060613 (2007-03-01), Kim
patent: 2009/0270391 (2009-10-01), Kubo et al.
patent: WO 03/106462 (2003-12-01), None
patent: WO 2004/018430 (2004-03-01), None
patent: WO 2005/021553 (2005-03-01), None
patent: WO 2005/080377 (2005-09-01), None
patent: 2005/116028 (2005-12-01), None
patent: 2005/121125 (2005-12-01), None
patent: 2006/014325 (2006-02-01), None
patent: WO 2006/010264 (2006-02-01), None
patent: 2006/108059 (2006-10-01), None
patent: 2006/116713 (2006-11-01), None
patent: WO 2007/125405 (2007-11-01), None
patent: WO 2008/054674 (2008-05-01), None
Ragan, J.A. et al., “Cross-Coupling Methods for the Large-Scale Preparation of an Imidazole—Theinopyridine: Synthesis of [2-(3-Methyl-3h-Imidazol-4-YL)-Thieno[3,2-b]Pyridin-7-YL]-(2-Methyl-1H-Indol-5-YL)-Amine”, Organic Process Research & Development, 2003, vol. 7, No. 5, pp. 676-683.
Boschelli, Diane H. et al., “Synthesis and SRC Kinase Inhibitory Activity of 2-Phenyl- and 2-Thienyl-7-Phenylaminothieno[3,2-b]Pyridine-6-Carbonitriles”, J. Med. Chem., 2005, vol. 48, pp. 3891-3902.
Munchhof, Michael J., “Design and SAR of Thienopyrimidine and Thienopyridine Inhibitors of VEGFR-2 Kinase Activity”, Bioorganic & Medicinal Chemistry Letters 14, 2004, pp. 21-24.
International Search Report and Written Opinion of the International Searching Authority, PCT/US2007/002352, Dec. 3, 2008.
Database Chemical Abstracts, Chemical Abstracts Service, SHIMIZU, “Preparation of quinoline derivatives as TGF β inhibitors”, XP002495469, Database accession No. 2004:182845, pp. 1-2, 2004.
Database Chemical Abstracts, Chemical Abstracts Service, SHIMIZU, “Preparation of pyridines and related compounds as TGF β inhibitors”, XP002495470, Database accession No. 2005:962244, pp. 1-3, 2005.
Blake James F.
Boyd Steven
De Meese Jason
Gaudino John J.
Marlow Allison L.
Array BioPharma Inc.
McDowell Brian
Viksnins Harris & Padys PLLP
Wilson James O
LandOfFree
Heterobicyclic thiophene compounds and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterobicyclic thiophene compounds and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterobicyclic thiophene compounds and methods of use will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2739589